Keyphrases
Anti-inflammatory Therapy
50%
Canakinumab
50%
Cantos
100%
Cardiovascular Events
50%
Cardiovascular Mortality
50%
Cardiovascular Safety
50%
Clinical Benefit
50%
Fatal Infection
50%
High Incidence
50%
Inflammatory Hypothesis
50%
Inflammatory Pathogenesis
100%
Interleukin-1β
50%
Lung Cancer
50%
Patient Subgroups
50%
Safety Concerns
50%
Therapeutic Targeting
100%
Thrombosis
50%
INIS
atherosclerosis
100%
cancer
50%
hypothesis
25%
inflammation
100%
interleukins
25%
lungs
25%
men
25%
mortality
25%
pathogenesis
100%
patients
25%
profits
25%
safety
25%
therapy
25%
thrombosis
25%
Medicine and Dentistry
Anti-Inflammatory Drug
100%
Atherosclerosis
100%
Canakinumab
50%
Cardiovascular Mortality
50%
Cardiovascular System
50%
Infection
50%
Interleukin 1beta
50%
Lung Cancer
50%
Malignant Neoplasm
50%
Thrombosis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
100%
Atherosclerosis
100%
Canakinumab
50%
Cardiovascular Mortality
50%
Infection
50%
Interleukin 1beta
50%
Lung Cancer
50%
Malignant Neoplasm
50%
Thrombosis
50%
Biochemistry, Genetics and Molecular Biology
Canakinumab
100%
Cardiovascular Mortality
100%
Interleukin-1
100%
Immunology and Microbiology
Atherosclerosis
100%
Canakinumab
50%
Cardiovascular Mortality
50%
Interleukin 1beta
50%